Related Experiment Videos

Endocrine function, morbidity, and mortality after surgery for craniopharyngioma

Insights

Childhood craniopharyngioma treatment frequently causes pituitary deficits, including hormone deficiencies and diabetes insipidus. These deficits pose significant long-term risks and can lead to medical emergencies and mortality.

Area of Science:

  • Pediatric Endocrinology
  • Pediatric Neurosurgery
  • Oncology

Background:

  • Craniopharyngioma is a common pediatric brain tumor affecting the pituitary gland.
  • Treatment of craniopharyngioma often leads to significant endocrine dysfunction.

Purpose of the Study:

  • To assess the incidence and long-term consequences of pituitary deficits following craniopharyngioma treatment in children.
  • To evaluate the mortality associated with these endocrine deficits.

Main Methods:

  • Retrospective review of medical records for 59 children treated for craniopharyngioma between 1960 and 1980.
  • Analysis of postoperative endocrine deficiencies and mortality data.

Main Results:

  • High rates of postoperative deficiencies were observed: growth hormone (100%), andrenocorticotropic hormone (72%), thyrotropin (65%), gonadotropin (94%), and diabetes insipidus (76%).
  • Fifteen patients died, with diabetes insipidus contributing to early deaths and anterior pituitary insufficiency suspected in later unexpected deaths.
  • Hypopituitarism caused medical emergencies in 12 patients, including symptomatic hypoglycemia in 9.

Conclusions:

  • Current craniopharyngioma treatment methods result in a high incidence of pituitary deficits in children.
  • These deficits present substantial long-term risks, including increased mortality and medical emergencies.

Related Concept Videos